• 41494 Citations
  • 98 h-Index
1985 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Merrick I Ross is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 20 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Circulating tumor cells and early relapse in node-positive melanoma

Lucci, A., Hall, C. S., Patel, S. P., Narendran, B., Bauldry, J. B., Royal, R. E., Karhade, M., Upshaw, J. R., Wargo, J. A., Glitza, I. C., Wong, M. K. K., Amaria, R. N., Tawbi, H., Diab, A., Davies, M. A., Gershenwald, J. E., Lee, J. E., Hwu, P. & Ross, M. I., Apr 15 2020, In : Clinical Cancer Research. 26, 8, p. 1886-1895 10 p.

Research output: Contribution to journalArticle

  • 4 Scopus citations

    Cumulative incidence and predictors of CNS metastasis for patients with American Joint Committee on Cancer 8th Edition stage III melanoma

    Haydu, L. E., Lo, S. N., McQuade, J. L., Amaria, R. N., Wargo, J., Ross, M. I., Cormier, J. N., Lucci, A., Lee, J. E., Ferguson, S. D., Saw, R. P. M., Spillane, A. J., Shannon, K. F., Stretch, J. R., Hwu, P., Patel, S. P., Diab, A., Wong, M. K. K., Glitza, I. C., Tawbi, H. & 9 others, Carlino, M. S., Menzies, A. M., Long, G. V., Lazar, A. J., Tetzlaff, M. T., Scolyer, R. A., Gershenwald, J. E., Thompson, J. F. & Davies, M. A., May 1 2020, In : Journal of Clinical Oncology. 38, 13, p. 1429-1441 13 p.

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    Functional annotation of melanoma risk loci identifies novel susceptibility genes

    Fang, S., Lu, J., Zhou, X., Wang, Y., Ross, M. I., Gershenwald, J. E., Cormier, J. N., Wargo, J., Sui, D., Amos, C. I. & Lee, J. E., 2020, In : Carcinogenesis. 41, 4, p. 452-457 6 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma

    Tetzlaff, M. T., Adhikari, C., Lo, S., Rawson, R. V., Amaria, R. N., Menzies, A. M., Wilmott, J. S., Ferguson, P. M., Ross, M. I., Spillane, A. J., Vu, K. A., Ma, J., Ning, J., Haydu, L. E., Saw, R. P. M., Wargo, J. A., Tawbi, H. A., Gershenwald, J. E., Long, G. V., Davies, M. A. & 1 others, Scolyer, R. A., 2020, (Accepted/In press) In : Annals of Oncology.

    Research output: Contribution to journalArticle

  • 3 Scopus citations